Cardiotoxicity of doxorubicin and other anthracycline derivatives
Open Access
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 7 (1) , 53-62
- https://doi.org/10.1067/mnc.2000.103324
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiationEuropean Journal Of Cancer, 1996
- Induction of apoptosis in chronic myelogenous leukemia lymphocytes by hydroxyurea and adriamycinCancer Letters, 1995
- Antineoplastic Drugs in 1990Drugs, 1990
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Clinical Pharmacokinetics of DoxorubicinClinical Pharmacokinetics, 1988
- Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapyThe American Journal of Medicine, 1987
- Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performanceAmerican Heart Journal, 1983
- Clinical and morphologic cardiac findings after anthracycline chemotherapyThe American Journal of Cardiology, 1983
- Dose-effect and structure-function relationships in doxorubicin cardiomyopathyAmerican Heart Journal, 1981
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979